Collectively, circRACGAP1 regulated the AKT signalling pathway_ia_inding to miR-22-3p in the progression of SLE, suggesting therapeutic targets for SLE treatment.
A novel circRNA, circRACGAP1, hampers the progression of systemic lupus erythematosus via miR-22-3p-mediated AKT signalling.